GATTO, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 439
Totale 439
Nazione #
IT - Italia 439
Totale 439
Città #
Rapallo 173
Genova 158
Genoa 102
Bordighera 6
Totale 439
Nome #
The effect of sodium restriction on iodine prophylaxis: a review, file e268c4ce-5142-a6b7-e053-3a05fe0adea1 207
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms, file e268c4ca-d085-a6b7-e053-3a05fe0adea1 83
Emerging drugs for the treatment of acromegaly, file e268c4cd-291a-a6b7-e053-3a05fe0adea1 37
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients, file e268c4cc-868c-a6b7-e053-3a05fe0adea1 15
Somatostatin receptor scintigraphy in thoracic diseases, file e268c4c6-00e6-a6b7-e053-3a05fe0adea1 13
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells, file e268c4c5-f80d-a6b7-e053-3a05fe0adea1 8
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors, file e268c4c9-d3c8-a6b7-e053-3a05fe0adea1 7
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation, file e268c4c6-1445-a6b7-e053-3a05fe0adea1 6
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective, file e268c4ce-18ec-a6b7-e053-3a05fe0adea1 6
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology, file e268c4c6-11e6-a6b7-e053-3a05fe0adea1 5
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case for, file e268c4c6-24a6-a6b7-e053-3a05fe0adea1 4
Diagnosis and Treatment of Parasellar Lesions, file e268c4cc-f19f-a6b7-e053-3a05fe0adea1 4
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES, file e268c4c5-ef2e-a6b7-e053-3a05fe0adea1 3
Does pasireotide directly modulate skeletal muscle metabolism?, file e268c4c9-d595-a6b7-e053-3a05fe0adea1 3
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects, file e268c4cd-ac32-a6b7-e053-3a05fe0adea1 3
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients, file 5b8b7099-858d-4628-9313-9e2cd0bfb031 2
Novel chimeric somatostatin analogs: facts and perspectives, file e268c4c5-f818-a6b7-e053-3a05fe0adea1 2
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database, file e268c4ca-4184-a6b7-e053-3a05fe0adea1 2
Somatostatin receptor ligands in the treatment of acromegaly, file e268c4ca-684d-a6b7-e053-3a05fe0adea1 2
Hormone receptors analysis in idiopathic progressive subglottic stenosis, file e268c4ca-825d-a6b7-e053-3a05fe0adea1 2
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients, file e268c4ca-b578-a6b7-e053-3a05fe0adea1 2
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly, file e268c4ca-c862-a6b7-e053-3a05fe0adea1 2
Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly, file e268c4ca-e780-a6b7-e053-3a05fe0adea1 2
Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center, file e268c4ca-e782-a6b7-e053-3a05fe0adea1 2
Octreotide-resistant acromegaly: Challenges and solutions, file e268c4cc-8162-a6b7-e053-3a05fe0adea1 2
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas, file e268c4cc-baf7-a6b7-e053-3a05fe0adea1 2
GH Replacement in the Elderly: Is It Worth It?, file e268c4ce-5dc8-a6b7-e053-3a05fe0adea1 2
Acromegaly Management in a Tertiary Referral Center After 1 Year of the Coronavirus 2019 Pandemic: A Double Challenge, file 8068eb0e-36a2-43ed-a0b1-0618738bf870 1
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length, file d3134048-35e2-4fea-9c8e-454464c8353a 1
Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?, file e268c4ca-a411-a6b7-e053-3a05fe0adea1 1
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas, file e268c4ca-d142-a6b7-e053-3a05fe0adea1 1
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review, file e268c4ca-edce-a6b7-e053-3a05fe0adea1 1
Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives, file e268c4ca-f17f-a6b7-e053-3a05fe0adea1 1
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression, file e268c4cc-2724-a6b7-e053-3a05fe0adea1 1
Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies., file e268c4cd-2d92-a6b7-e053-3a05fe0adea1 1
Aggressive and malignant prolactinomas, file e268c4cd-3846-a6b7-e053-3a05fe0adea1 1
Editorial: Resistance to Medical Therapy in Pituitary Tumors, file e893adcd-9e5f-4152-bab6-c653305a7aa1 1
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide, file f3cbc43b-0f91-424d-b76f-25c7a9a9f6fe 1
Totale 439
Categoria #
all - tutte 1.089
article - articoli 1.089
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/202028 1 0 0 0 2 0 0 6 9 6 2 2
2020/202136 1 5 4 1 6 3 2 7 1 3 0 3
2021/202291 2 0 3 0 1 0 2 1 21 17 32 12
2022/2023194 8 13 24 31 26 21 16 21 10 4 15 5
2023/202480 5 4 12 3 5 9 11 14 3 9 5 0
Totale 439